Frontiers in Molecular Neuroscience · 2018 · 61 citations · 28 references
Life SciencesNeurosciencePharmacologyAutophagyCellular NeuroscienceNeuropharmacologyEndoplasmic Reticulum Stress-induced ApoptosisNeurodegenerative DiseasesNeurodegenerative DisordersNeuroprotectionNeuroprotective PharmacologyParkinson DiseaseDopaminergic NeurodegenerationDopaminergic Neuron DeathDopaminergic NeuroprotectionEndoplasmic Reticulum Stress ModulationEr Stress In NeurodegenerationMorphine BiosynthesisNeuroprotective AgentsNeuroprotective Mechanisms
Parkinson’s disease (PD) is a common neurodegenerative disease characterized the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc). Brain endogenous morphine biosynthesis was reported to be impaired in PD patients and exogenous morphine attenuated 6-hydroxydopamine (6-OHDA)-induced cell death in vitro. However, the mechanisms underlying neuroprotection of morphine in PD are still unclear. In the present study, we investigated the neuroprotective effects of low-dose morphine in cellular and animal models of PD and the possible underlying mechanisms. Herein, we found 6-OHDA and rotenone decreased the mRNA expression of key enzymes involved in endogenous morphine biosynthesis in SH-SY5Y cells. Incubation of morphine prevented 6-OHDA-induced apoptosis, restored mitochondrial membrane potential, and inhibited the accumulation of intracellular reactive oxygen species (ROS) in SH-SY5Y cells. Furthermore, morphine attenuated the 6-OHDA-induced endoplasmic reticulum (ER) stress possible by activating autophagy in SH-SY5Y cells. Finally, oral application of low-dose morphine significantly improved midbrain tyrosine hydroxylase (TH) expression, decreased apomorphine-evoked rotation and attenuated pain hypersensitivity in a 6-OHDA-induced PD rat model, without the risks associated with morphine addiction. Feeding of low-dose morphine prolonged the lifespan and improved the motor function in several transgenic Drosophila PD models in gender, genotype, and dose-dependent manners. Overall, our results suggest that neuroprotection of low-dose morphine may be mediated by attenuating ER stress and oxidative stress, activating autophagy, and ameliorating mitochondrial function. Keywords: Morphine; Parkinson’s disease; Neuroprotection; Autophagy; ER stress
28
Autophagy maintains stemness by preventing senescence
Laura García‐Prat, Marta Martínez‐Vicente, Eusebio Perdiguero et al. · Nature · 2016 · 1.4K citations
ER stress: Autophagy induction, inhibition and selection
Harun-Or Rashid, Raj Kumar Yadav, Hyung‐Ryong Kim et al. · Autophagy · 2015 · 801 citations · Full text
Pain in Parkinson’s disease: Prevalence and characteristics
A. G. Beiske, Jon H. Loge, A. Rønningen et al. · Pain · 2008 · 492 citations
Medicine, Neurology, Pain Management +15
A <i>Drosophila</i> model for <i>LRRK2</i> -linked parkinsonism
Zhaohui Liu, Xiaoyue Wang, Yi Yu et al. · Proceedings of the National Academy of Sciences · 2008 · 281 citations · Full text